Aging and the brain renin-angiotensin system: Insights from studies in transgenic rats

Cleveland Clinic Journal of Medicine

Volumn 74, Issue SUPPL.1, 2007, Pages 95-98

  Diz, Debra I ^a   Kasper, Sherry O ^a   Sakima, Atsushi ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL; BRAIN; CARDIOVASCULAR DISEASE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TRANSGENIC ANIMAL;

AGING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; CARDIOVASCULAR DISEASES; HUMANS; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 34249862899     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.Suppl_1.S95     Document Type: Note

References (34)

1. Diz DI, Averill DB. Angiotensin II/autonomic interactions. In: Robertson D, Biaggioni I, Burnstock G, Law PA, eds. Primer on the Autonomic Nervous System. San Diego, CA: Elsevier Academic Press; 2004:168-171.
2. Basso N, Paglia N, Stella I, et al. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 2005; 128:247-252.
3. Linz W, Jessen T, Becker RHA, Scholkens BA, Wiemer G. Longterm ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997; 96:3164-3172.
4. Ferder L, Inserra F, Romano L, Ercole L, Pszenny V. Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse. Am J Physiol Cell Physiol 1993; 34:C15-C18.
5. de Cavanagh EMV, Piotrkowski B, Basso N, et al. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 2003; 17:1096-1098.
6. Gilliam-Davis S, Payne VS, Kasper SO, Robbins ME, Diz DI. Differential regulation of circulating and intra-renal reninangiotensin systems and improved metabolic function in Fisher 344 rats after long-term AT1 receptor blockade. Hypertension 2005; 46:818. Abstract.
7. Kasper SO, Basso N, Kurnjek ML, et al. Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade. Am J Nephrol 2005; 25:335-341.
8. Carter CS, Cesari M, Ambrosius WT, et al. Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats. J Gerontol A Biol Sci Med Sci 2004; 59:416-423.
9. Anderson S. Ageing and the renin-angiotensin system. Nephrol Dial Transplant 1997; 12:1093-1094.
10. Oden SD, Ganten D, Ferrario CM, Chappell MC, Diz DI. Rats with low brain angiotensinogen maintain normal levels of insulin and components of the circulating and intra-renal renin-angiotensin systems during aging. FASEB J 2004; 18:A738. Abstract.
11. Groban L, Pailes NA, Bennett CDL, et al. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats. J Gerontol A Biol Sci Med Sci 2006; 61:28-35.
12. Chappell MC, Diz DI, Gallagher PE. The renin-angiotensin system and the exocrine pancreas. JOP (online) 2001; 2:33-39.
13. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001; 79:76-102.
14. Brosnihan KB, Diz DI, Schiavone MT, Averill DB, Ferrario CM. Approaches to establish angiotensin II as a neurotransmitter. In: Buckley JP, Ferrario CM, eds. Brain Peptides and Catecholamines in Cardiovascular Regulation. New York, NY: Raven Press; 1987:313-328.
15. Averill DB, Diz DI. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull 2000; 51:119-128.
16. Diz DI, Jessup JA, Westwood BM, et al. Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin Exper Pharmacol Physiol 2002; 29:473-482.
17. Diz DI. Approaches to establishing angiotensin II as a neurotransmitter revisited. Hypertension 2006; 47:334-336.
18. Schinke M, Baltatu O, Bohm M, et al. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A 1999; 96:3975-3980.
19. Huang BS, Ganten D, Leenen FH. Responses to central Na(+) and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen. Hypertension 2001; 37:683-686.
20. Kasper SO, Carter CS, Ferrario CM, et al. Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems. Physiol Genomics 2005; 23:311-317.
21. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counter-regulatory actions of angiotensin-(1-7). Hypertension 1997; 30:535-541.
22. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. In: Suzuki H, Saruta T, eds. Kidney and Blood Pressure Regulation. Basel, Switzerland: Karger; 2004:77-89.
23. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998; 31:699-705.
24. Sakima A, Averill DB, Gallagher PE, et al. Impaired heart rate baroreflex in older rats. Role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension 2005; 46:333-340.
25. Gegick S, Garcia-Espinosa MA, Gallagher PE, et al. Reduced formation of Ang-(1-7) by ACE2 in dorsal medulla oblongata of Sprague-Dawley (SD) and ASrAogen rats during aging [abstract]. FASEB J 2006; 20:A1209.
26. Giza BK, Scott TR, Vanderweele DA. Administration of satiety factors and gustatory responsiveness in the nucleus tractus solitarius of the rat. Brain Res Bull 1992; 28:637-639.
27. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997; 138:839-842.
28. Diz DI, Barnes KL, Ferrario CM. Functional characteristics of neuropeptides in the dorsal medulla oblongata and vagus nerve. Fed Proc 1987; 46:30-35.
29. Berthoud HR. A new role for leptin as a direct satiety signal from the stomach. Am J Physiol Regul Integr Comp Physiol 2005; 288: R796-R797.
30. Schwartz GJ, Moran TH. Leptin and neuropeptide Y have opposing modulatory effects on nucleus of the solitary tract neurophysiological responses to gastric loads; implications for the control of food intake. Endocrinology 2002; 143:3779-3784.
31. Ellacott KLJ, Cone RD. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res 2004; 59:395-408.
32. Diz DI, Barnes KL, Ferrario CM. Contribution of the vagus nerve to angiotensin II binding in the canine medulla. Brain Res Bull 1986; 17:497-505.
33. Diz DI, Block CH, Barnes KL, Ferrario CM. Correlation between angiotensin II binding sites and substance P in the canine brain stem. J Hypertension 1986; 4(Suppl 6):S468-S471.
34. Diz DI. Commentary: angiotensin II receptors in central nervous system physiology. In: Husain A, Graham R, eds. Drugs, Enzymes and Receptors of the Renin Angiotensin System: Celebrating a Century of Discovery. Amsterdam: Harwood Academic Publishers; 1999:45-51.